Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

RxSight (RXST) EPS (Basic) (2020 - 2026)

RxSight posted quarterly EPS (Basic) of -$0.38 for Q1 2026, down 90.0% year-on-year from -$3.8 in Q1 2025, and down 72.73% on a QoQ basis from -$0.22 in Q4 2025.

RxSight (RXST) has 7 years of EPS (Basic) data on file, last reported at -$0.38 in Q1 2026.

  • For the quarter ending Q1 2026, EPS (Basic) fell 90.0% year-over-year to -$0.38; the trailing twelve-month figure through Mar 2026 stood at -$1.13 (down 68.66% YoY), and the FY2025 full-year result was -$0.95, down 33.8% from the prior year.
  • EPS (Basic) for Q1 2026 stood at -$0.38, down from -$0.22 in the prior quarter.
  • Across five years, EPS (Basic) topped out at -$0.15 in Q4 2024 and bottomed at -$0.64 in Q1 2022.
  • The 5-year median for EPS (Basic) is -$0.29 (2025), against an average of -$0.35.
  • Peak annual rise in EPS (Basic) reached 81.4% in 2022, while the deepest fall reached 711.11% in 2022.
  • A 5-year view of EPS (Basic) shows it stood at -$0.55 in 2022, then jumped by 54.55% to -$0.25 in 2023, then surged by 40.0% to -$0.15 in 2024, then slumped by 46.67% to -$0.22 in 2025, then sank by 72.73% to -$0.38 in 2026.
  • The last three EPS (Basic) figures came in at -$0.38 (Q1 2026), -$0.22 (Q4 2025), and -$0.24 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 0.62
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 1.95
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.89
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 0.90
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 0.66
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 0.52
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 0.85
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 2.25
10 RxSight 215.82 Mn -2.06 Mn 23.50 Mn -0.38

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -0.38
Dec 31, 2025 -0.22
Sep 30, 2025 -0.24
Jun 30, 2025 -0.29
Mar 31, 2025 -0.20
Dec 31, 2024 -0.15
Sep 30, 2024 -0.16
Jun 30, 2024 -0.16
Mar 31, 2024 -0.25
Dec 31, 2023 -0.25
Sep 30, 2023 -0.35
Jun 30, 2023 -0.40
Mar 31, 2023 -0.42
Dec 31, 2022 -0.55
Sep 30, 2022 -0.61
Jun 30, 2022 -0.61
Mar 31, 2022 -0.64
Dec 31, 2021 0.09
Sep 30, 2021 -0.68
Jun 30, 2021 -3.28
Mar 31, 2021 -1.70
Dec 31, 2020 0.91
Jun 30, 2020 -4.66